New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Novavax, Inc.

NVAX

Healthcare Biotechnology

Novavax, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 64.7% from fiscal 2024.

Revenue
−3.05%
EPS
n/m
Free cash flow
n/m
Total debt
+19.3%

Quarter to September 2026, against a year earlier

7.76 0.03 +0.39%
Market cap
$1.3B
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
5/9
ROIC
0.00%
Net debt / EBITDA
−1.0×
Payout ratio
—

Novavax, Inc. (NVAX) Return on invested capital

Alert me on Return on invested capital

Novavax, Inc.'s return on invested capital over the twelve months to Sep 30, 2026 was 0.00%, down 0.0 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from −373.8% (fiscal 2016) to 0.00% (fiscal 2025) — the current reading is the highest in ten years. That is in line with the Biotechnology industry median of 0.00% and in line with the Healthcare sector median of 0.00%.

Return on invested capital, annual

Embed this chart

Annual newest first

Period Return on invested capital Change (points)
FY2025 0.00% 0.00
FY2024 0.00% 0.00
FY2023 0.00% 0.00
FY2022 0.00% 0.00
FY2021 0.00% 141.24
FY2020 −141.2% 1.43
FY2019 −142.7% 82.51
FY2018 −225.2% 126.75
FY2017 −351.9% 21.84
FY2016 −373.8% (10.46)

Against its own ten years

Low −373.8% High 0.00%
Ten-year median −141.2%
Current reading's percentile 100

Return on invested capital against peers

Company Return on invested capital
NBTX Nanobiotix S.A. - Sponsored ADR compare 0.00%
NVAX Novavax, Inc. 0.00%
OCUL Ocular Therapeutix, Inc. compare 0.00%
TSHA Taysha Gene Therapies, Inc. compare 0.00%
GENB Generate Biomedicines, Inc. compare 0.00%
TYRA Tyra Biosciences, Inc. compare 0.00%
NUVB Nuvation Bio Inc. compare 0.00%
MNKD MannKind Corporation compare −2.58%
LBRX LB Pharmaceuticals Inc compare −686.2%
Biotechnology industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on NVAX